anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

192,421-192,480 of 319,975

filter-aware
06
The slide uses a high-energy lifestyle image to transition into financial reporting.Deezer | Results Presentation Deck | 16 slides · Deezer
Conference presentation Investor relations 1 hit
07
Deezer | Results Presentation Deck | 16 slidesDeezer | Results Presentation Deck | 16 slides · Deezer
Conference presentation Investor relations Beat · KPI OverviewLoop · Cost Of Inaction1 hit
08
The slide uses stacked bar charts to show revenue composition and YoY growth percentages.Deezer | Results Presentation Deck | 16 slides · Deezer
Conference presentation Investor relations Beat · KPI OverviewLoop · Cost Of Inaction1 hit
09
The slide uses a waterfall-style bracket to show YoY and QoQ changes for subscribers and ARPU.Deezer | Results Presentation Deck | 16 slides · Deezer
Conference presentation Investor relations Beat · KPI OverviewLoop · Cost Of Inaction1 hit
10
The slide uses a waterfall-style annotation to show YoY and QoQ percentage changes above the bar charts.Deezer | Results Presentation Deck | 16 slides · Deezer
Conference presentation Investor relations Beat · KPI OverviewLoop · Cost Of Inaction1 hit
11
Deezer | Results Presentation Deck | 16 slidesDeezer | Results Presentation Deck | 16 slides · Deezer
Conference presentation Investor relations 1 hit
12
Deezer | Results Presentation Deck | 16 slidesDeezer | Results Presentation Deck | 16 slides · Deezer
Conference presentation Investor relations Beat · Satisfaction1 hit
13
Deezer | Results Presentation Deck | 16 slidesDeezer | Results Presentation Deck | 16 slides · Deezer
Conference presentation Investor relations 1 hit
14
Deezer | Results Presentation Deck | 16 slidesDeezer | Results Presentation Deck | 16 slides · Deezer
Conference presentation Investor relations Loop · Pareto Focus1 hit
15
Deezer | Results Presentation Deck | 16 slidesDeezer | Results Presentation Deck | 16 slides · Deezer
Conference presentation Investor relations Loop · Pareto Focus1 hit
16
The slide uses a background image of a building with projected images in the windows.Deezer | Results Presentation Deck | 16 slides · Deezer
Conference presentation Investor relations 1 hit
01
Slide 1
Deliveroo | Results Presentation Deck | 16 slidesDeliveroo | Results Presentation Deck | 16 slides · Deliveroo
Conference presentation Investor relations Beat · Attention1 hit
02
Standard financial reporting disclaimer slide.Deliveroo | Results Presentation Deck | 16 slides · Deliveroo
Conference presentation Investor relations Beat · Attention1 hit
03
The slide uses a numbered list format to present four distinct performance highlights.Deliveroo | Results Presentation Deck | 16 slides · Deliveroo
Conference presentation Investor relations Beat · Attention1 hit
04
The slide uses a two-column layout to contrast operational engagement metrics with financial results.Deliveroo | Results Presentation Deck | 16 slides · Deliveroo
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
05
The slide uses a consistent color scheme where the most recent quarter (Q3 22) is highlighted in teal.Deliveroo | Results Presentation Deck | 16 slides · Deliveroo
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
06
The slide uses a combination of a bar chart for historical trends and a waterfall chart for bridge analysis.Deliveroo | Results Presentation Deck | 16 slides · Deliveroo
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
07
Includes year-on-year growth percentages for active consumers.Deliveroo | Results Presentation Deck | 16 slides · Deliveroo
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
08
The slide uses a dual-bar chart structure to compare Orders and GTV, with annotations for YoY growth and CAGR.Deliveroo | Results Presentation Deck | 16 slides · Deliveroo
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
09
The slide uses a dual-metric bar chart approach with YoY growth and CAGR indicators.Deliveroo | Results Presentation Deck | 16 slides · Deliveroo
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
10
The slide provides a clear bridge between past performance and future expectations, highlighting the update to 2022 guidance while maintaining long-term targets.Deliveroo | Results Presentation Deck | 16 slides · Deliveroo
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
11
The slide uses a combination of a line chart for Gross Profit Margin and a bar chart for Adjusted EBITDA Margin, with a forward-looking 'implied' projection for H2 2022.Deliveroo | Results Presentation Deck | 16 slides · Deliveroo
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
12
Deliveroo corporate presentation slide.Deliveroo | Results Presentation Deck | 16 slides · Deliveroo
Conference presentation Investor relations Beat · Action1 hit
13
Deliveroo | Results Presentation Deck | 16 slidesDeliveroo | Results Presentation Deck | 16 slides · Deliveroo
Conference presentation Investor relations Beat · Action1 hit
14
Deliveroo | Results Presentation Deck | 16 slidesDeliveroo | Results Presentation Deck | 16 slides · Deliveroo
Conference presentation Investor relations 1 hit
15
Data is segmented by region and includes year-over-year growth percentages and margins as a percentage of GTV.Deliveroo | Results Presentation Deck | 16 slides · Deliveroo
Conference presentation Investor relations 1 hit
16
Deliveroo | Results Presentation Deck | 16 slidesDeliveroo | Results Presentation Deck | 16 slides · Deliveroo
Conference presentation Investor relations 1 hit
01
Slide 1
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
02
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
03
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
04
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
05
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
06
The slide uses a chevron-based table structure to link disease states to market validation.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations Beat · Market Size1 hit
07
The diagram uses a branching logic to show how core pipelines lead to multiple indications/products, which then feed into a value-maximization arrow.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
08
The slide uses a Gantt-style visualization to show progress of drug candidates.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
09
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations Beat · Team1 hit
10
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations Beat · Team1 hit
11
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations Beat · Team1 hit
12
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
13
The slide uses a biological process diagram to illustrate the mechanism of immune cell activation.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
14
The slide uses a visual metaphor to explain immune evasion.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
15
The slide uses a visual metaphor of a dendritic cell connecting to a stacked list of therapeutic outcomes.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
16
The slide uses a process flow framework to explain the production of an off-the-shelf cell therapy.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
17
The slide presents visual evidence (photos of tumors) alongside quantitative bar charts showing efficacy metrics.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
18
The slide uses a ribbon-style process diagram to show progression from proof-of-concept to clinical trials.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
19
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
20
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
21
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
22
The slide uses a process flow diagram to explain the therapeutic mechanism.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
23
The slide uses a ribbon-style timeline visualization.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
24
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
25
The slide uses a list of key value propositions for the therapy.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
26
The chart shows a significant drop in viral load after day 14, maintaining a low level from day 145 onwards.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
27
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
28
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
29
Mentions a specific cost range ($300k-$450k) as a pain point for current CAR-T therapies.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
30
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
31
Uses a vertical process-style list with icons to denote key product attributes.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
32
The diagram uses a visual contrast between infected and uninfected cells to demonstrate specificity.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
33
The slide uses a ribbon-style process diagram to show sequential milestones.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit